Literature DB >> 16540321

Prevalence of Parkinson's disease in metropolitan and rural Queensland: a general practice survey.

Catherine M Peters1, Coral E Gartner, Peter A Silburn, George D Mellick.   

Abstract

The prevalence of idiopathic Parkinson's disease (IPD) in Australia is unclear. We estimated the prevalence of IPD, and other forms of parkinsonism, through the study of typical caseloads in general practice. A random sample of general practitioners (GPs) throughout Queensland (401 responses from 528 validated practice addresses) was asked to estimate the numbers of patients with IPD and parkinsonism seen in the preceding year. The estimated prevalence of diagnosed IPD in Queensland was 146 per 100,000 (95% CI=136-155). A further 51 per 100,000 in the population were suspected by doctors to have IPD without formal diagnosis, whereas another 51 per 100,000 people may have non-idiopathic parkinsonism. Idiopathic Parkinson's disease was more common in rural than metropolitan areas. Although most GPs were confident in making diagnoses of IPD, the majority had little or no confidence in their ability to treat the disease, especially in its later stages. Support from neurologists was perceived by GPs to be very good in cities, but poor in remote areas.

Entities:  

Mesh:

Year:  2006        PMID: 16540321     DOI: 10.1016/j.jocn.2005.04.015

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Knowledge and attitudes towards genetic testing in those affected with Parkinson's disease.

Authors:  Tracey M Scuffham; Aideen McInerny-Leo; Shu-Kay Ng; George Mellick
Journal:  J Community Genet       Date:  2013-09-10

2.  Time trends in incidence of Parkinson's disease diagnosis in UK primary care.

Authors:  Laura Horsfall; Irene Petersen; Kate Walters; Anette Schrag
Journal:  J Neurol       Date:  2012-12-23       Impact factor: 4.849

Review 3.  Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.

Authors:  Dénes Zádori; Péter Klivényi; Imola Plangár; József Toldi; László Vécsei
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

4.  Australian Parkinson's Genetics Study (APGS): pilot (n=1532).

Authors:  Svetlana Bivol; George D Mellick; Jacob Gratten; Richard Parker; Aoibhe Mulcahy; Philip E Mosley; Peter C Poortvliet; Adrian I Campos; Brittany L Mitchell; Luis M Garcia-Marin; Simone Cross; Mary Ferguson; Penelope A Lind; Danuta Z Loesch; Peter M Visscher; Sarah E Medland; Clemens R Scherzer; Nicholas G Martin; Miguel E Rentería
Journal:  BMJ Open       Date:  2022-02-25       Impact factor: 3.006

5.  Commentary.

Authors:  Weerasak Muangpaisan
Journal:  J Neurosci Rural Pract       Date:  2012-09

Review 6.  Parkinson's Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care.

Authors:  Uduak Williams; Oliver Bandmann; Richard Walker
Journal:  J Mov Disord       Date:  2018-05-30

7.  A cross-sectional study of knowledge and practices in the management of patients with Parkinson's disease amongst public practice-based general practitioners and geriatricians.

Authors:  Isis Claire Z Y Lim; Seyed Ehsan Saffari; Shermyn Neo
Journal:  BMC Health Serv Res       Date:  2022-01-20       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.